Skip to content

Neonatal Precursors of Neurodevelopment

Neonatal Precursors of Neurodevelopment

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04703010
Acronym
NEOPRENE
Enrollment
90
Registered
2021-01-11
Start date
2022-03-01
Completion date
2024-09-01
Last updated
2022-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Birth

Brief summary

The NEOPRENE project proposes to examine processes that are among the earliest precursors of cognitive functions and assess 1) the relationship between neonatal cognitive precursors and cortical structure, structural connectivity and functional connectivity at birth and 2) the relationship between neonatal cognitive precursors and neurodevelopment.

Interventions

DEVICEElectroencephalography-Near infrared spectroscopy

Brain activity will be measured using 128-channel EEG and 2 channel NIRS during tactile stimulation (15 minutes sequence of vibrations) while the newborn is asleep.

DEVICEMagnetic resonance imaging

Structural (T1-T2), siffusion tensor imaging and blood-oxygen level dependant signal will be acquired in a subset of 40 subjects (20 minutes while asleep)

Cognitive evaluation at age 2 (Parental questionnaires on sensory profiles, executive functions and neurodevelopmental disorders screening, child tests : movement assessment battery, Laby, Head-toes-shoulders-knees)

Sponsors

University Hospital, Caen
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Longitudinal study with measures at birth and at age 2.

Eligibility

Sex/Gender
ALL
Age
No minimum to 2 Years
Healthy volunteers
No

Inclusion criteria

* Preterm newborn (born \< 34 weeks + 6days)

Exclusion criteria

* Brain injury * Respiratory assistance on measurement day * Infection on measurement day * Sedation on measurement day * Parents \< 18 years old or unable to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Electroencephalography evoked response amplitude35 weeks of gestational ageElectrical field potential changes in the parietal and frontal cortices
Frontal-parietal functional connectivity35 weeks GASynchronization at rest using blood-oxygen level dependent signal in magnetic resonance imaging
Near infrared spectroscopy evoked response amplitude35 weeks of gestational ageOxygenated hemoglobin concentration changes in the somatosensory cortex
Grey matter volume in the somatosensory cortex35 weeks GAThickness measured on T2 images in magnetic resonance imaging
Frontal-parietal structural connectivity35 weeks GATractography using Diffusion tensor Imaging in magnetic resonance imaging
Quality of cognitive development2 years oldQualitative composite assessment using clinical interview, routine pediatric screening and questionnaires (full sensory profile, preschooler Behavior Rating Inventory of Executive Function)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026